Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Nina Schor MD, PhD
Nina F. Schor MD, PhD Advisory Board
Avindra Nath MD
Avindra Nath MD Associate Editor
Marinos Dalakas MD, FAAN
Marinos C. Dalakas MD, FAAN Advisory Board
See All Experts
featured
Published in Neurology

Expert Opinion / Commentary · November 06, 2017

2017 Top Stories in Neurology: Prophylaxis of Migraine in Children and Adolescents

Nina Schor MD, PhD

 

 Save  Recommend
 Share

Additional Info

  1. Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S; American Academy of Neurology Quality Standards Subcommittee; Practice Committee of the Child Neurology Society. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63(12):2215-2224.
  2. Powers SW, Coffey CS, Chamberlin LA, et al. Trial of amitriptyline, topiramate, and placebo for pediatric migraine. N Engl J Med. 2017;376(2):115-124.
  3. Sherwood M, Goldman RD. Effectiveness of riboflavin in pediatric migraine prevention. Can Fam Physician. 2014;60(3):244-246.
  4. Rakel D. Powerful placebo. PracticeUpdate Primary Care. Accessed 10/26/2017.

Further Reading

Most Read This Week

Recently Updated